van Rooij J, Schwartzenberg S G, Mulder P G, Baarsma S G
Eye Hospital Rotterdam, Rotterdam, Netherlands.
Br J Ophthalmol. 1999 Nov;83(11):1277-82. doi: 10.1136/bjo.83.11.1277.
To investigate the effect of additional oral vitamins C and E on acute anterior uveitis.
A placebo controlled double masked study on the effect of vitamin C 500 mg in combination with vitamin E 100 mg twice daily in 145 patients with acute anterior uveitis. As a primary end point variable, laser cell/flare measurements were performed. Best corrected and stenopeic visual acuity (VA) testing and clinical variable scores were measured.
Laser flare measurements (ph/s) before treatment were 207.1 (SD 258) in the vitamin group and 143.6 (156) in the placebo group. After 3 days corresponding values were 80.2 (129) and 54.7 (82), after 7 days 89.2 (187) (12.5) and 85.8 (208), after 14 days 47.1 (109.5) and 40.5 (116) after 28 days 23.1 (53.6) and 23.1 (48), and after 56 days 15.6 (26) and 15.3 (17). There was no significant difference in time trend between the two treatment groups (RMANOVA; p = 0.53). Baseline VA (logMAR) was 0.106 (0.241) in the vitamin group and 0.128 (0.456) in the placebo group. VA after 3 days was 0. 236 (0.293) and 0.344 ( 0.489), after 7 days 0.204 (0.292) and 0.292 (0.479), after 14 days 0.162 (0.274) and 0.193 (0.454), after 28 days 0.096 (0.232) and 0.158 (0.436), and 0.026 (0.213) and 0.106 (0. 437) after 56 days. Although no significant difference in time trend was detected, evaluation of the VA data of the last time point (56 days) by means of the Mann-Whitney test showed a significantly better VA in the vitamin group (p = 0.01).
There was no significant effect of vitamins C and E on laser flare measurements. The significant effect of the oral vitamins on visual acuity at 8 weeks after start of the oral vitamins C and E may indicate a protective effect in patients with acute anterior uveitis.
研究额外口服维生素C和维生素E对急性前葡萄膜炎的影响。
一项安慰剂对照双盲研究,纳入145例急性前葡萄膜炎患者,给予维生素C 500毫克联合维生素E 100毫克,每日两次。以激光细胞/光斑测量作为主要终点变量。测量最佳矫正视力和小孔视力(VA)以及临床变量评分。
治疗前,维生素组的激光光斑测量值(ph/s)为207.1(标准差258),安慰剂组为143.6(156)。3天后相应值分别为80.2(129)和54.7(82),7天后为89.2(187)(12.5)和85.8(208),14天后为47.1(109.5)和40.5(116),28天后为23.1(53.6)和23.1(48),56天后为15.6(26)和15.3(17)。两组治疗组在时间趋势上无显著差异(重复测量方差分析;p = 0.53)。维生素组的基线视力(logMAR)为0.106(0.241),安慰剂组为0.128(0.456)。3天后视力分别为0.236(0.293)和0.344(0.489),7天后为0.204(0.292)和0.292(0.479),14天后为0.162(0.274)和0.193(0.454),28天后为0.096(0.232)和0.158(0.436),56天后为0.026(0.213)和0.106(0.437)。虽然未检测到时间趋势上的显著差异,但通过曼-惠特尼检验对最后一个时间点(56天)的视力数据进行评估显示,维生素组的视力显著更好(p =
0.01)。
维生素C和维生素E对激光光斑测量无显著影响。口服维生素C和维生素E开始后8周时,口服维生素对视力有显著影响,这可能表明对急性前葡萄膜炎患者有保护作用。